Ìý NEWS ARCHIVE


Cone Snail Venom Shows Potential for Treating Severe Malaria

By | February 18, 2021

A study by researchers at FAU and collaborators finds anti-adhesion drugs derived from cone snail venom may hold the key to treating malaria, COVID-19, AIDS and other diseases using blockage therapies.

FAU Launches COVID-19 Registry and Repository to Advance Research

By | February 15, 2021

FAU has launched a registry and repository to contribute to new discoveries and knowledge related COVID-19 and is currently enrolling participants with prior documented positive test reports.

FAU Develops Simplified COVID-19 Diagnostic Method to Ramp Up Testing

By | January 12, 2021

Researchers from the Schmidt College of Medicine have developed a simplified COVID-19 testing protocol that is rapid, reliable and offers distinct advantages with less labor, expertise and equipment needed.

FAU's Lawrence Toll Among World's Most 'Highly Cited Researchers'

By | December 9, 2020

Lawrence Toll, Ph.D., has been named by The Web of Science(TM) among its most Highly Cited Researchers(TM). His publications rank in the top 1 percent by citations according to Clarivate(TM).

FAU and Memorial Healthcare System Establish Research Partnership

By | November 16, 2020

FAU and Memorial Healthcare System have formed a research partnership, which combines their expertise and resources in clinical research, clinical trials, basic research and translational biomedical research.

Dopamine Surge Reveals How Even for Mice, 'There's No Place Like Home'

By | November 12, 2020

A study by FAU neuroscientists demonstrates how 'coming home' produces a signal of comfort in mice and is the first to show that home evokes a surge of dopamine that mimics the response to a dose of cocaine.

What's That Growing on Your Face Mask?

By | November 9, 2020

FAU Schmidt College of Medicine researcher has developed a novel device to conveniently sanitize contaminated masks and other items at home or at work and has received a provisional patent for the technology.

Remdesivir for COVID-19: FDA Approved but Still Unproven

By | October 29, 2020

FAU Schmidt College of Medicine researchers reviewed the most reliable data from remdesivir randomized trials. In a commentary, they conclude that effective public health strategies are more urgently needed.

Opioid Use Disorder? Electronic Health Records Help Pinpoint Patients

By | October 21, 2020

A retrospective cross-sectional study by FAU Schmidt College of Medicine researchers and collaborators, shows that information in electronic health records may help identify patients with opioid use disorder.

FAU Researchers Receive $1.3 Million NIH Grant for Stem Cell Research

By | October 14, 2020

FAU Schmidt College of Medicine researchers will analyze stem cell activation with a focus on age-related and degenerative diseases to provide a basis for the development of regenerative therapies.

Ìý